INTRODUCTIONSurgical resection is the cornerstone for the treatment of retroperitoneal soft tissue sarcoma (RPS), and it has the aim of minimizing marginality. Indeed, the local treatment is of utmost importance in the absence of validated systemic therapies in adjuvant setting. Moreover, we await the final results of STRASS, a randomized study evaluating the benefit of preoperative radiotherapy. Recently, a radical surgical approach involving en bloc resection of the tumor with adherent organs or structures has been advocated for optimizing survival and has led to a significant drop in the local recurrence rates compared to the historical recurrence rates. This radical surgical approach is safe when it is carried out at a specialist sarcoma center, but the decision regarding whether to resect an organ must be made by an experienced surgeon when considering histological subtype and morbidity. In particular, major vessel resections significantly increase the occurrence of post‐operative complications. In the retroperitoneal space, vascular sarcomas originating from the walls of the vessels co‐exist with retroperitoneal soft tissue sarcomas with secondary vascular involvement. In the latter, the retroperitoneal location and often the evolved size lead to the frequent involvement of the major vascular structures and may become a limitation for complete
Journal of Surgical Oncology – Wiley
Published: Jan 1, 2018
Keywords: ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
It’s easy to organize your research with our built-in tools.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud